Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells. (Record no. 9344254)

MARC details
000 -LEADER
fixed length control field 01359 a2200397 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513131420.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199712s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0007-0920
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1038/bjc.1997.556
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Marth, C
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19971204
245 00 - TITLE STATEMENT
Title Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. British journal of cancer
Date of publication, distribution, etc. 1997
300 ## - PHYSICAL DESCRIPTION
Extent 1328-32 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cisplatin
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Resistance, Neoplasm
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Genes, erbB-2
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HLA-DR Antigens
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-gamma
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ovarian Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tumor Cells, Cultured
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Widschwendter, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kaern, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jørgensen, N P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Windbichler, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zeimet, A G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tropé, C
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Daxenbichler, G
773 0# - HOST ITEM ENTRY
Title British journal of cancer
Related parts vol. 76
-- no. 10
-- p. 1328-32
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1038/bjc.1997.556">https://doi.org/10.1038/bjc.1997.556</a>
Public note Available from publisher's website

No items available.